Mineralys Therapeutics, Inc. (MLYS)
(Real Time Quote from BATS)
$13.13 USD
-0.32 (-2.38%)
Updated Jun 7, 2024 02:24 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.74 | 0.00% |
Earnings Summary
For their last quarter, Mineralys Therapeutics, Inc. (MLYS) reported earnings of -$0.70 per share, missing the Zacks Consensus Estimate of -$0.68 per share. This reflects a negative earnings surprise of 2.94%. Look out for MLYS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.74 per share, reflecting a year-over-year decrease of 138.71%.
Earnings History
Price & Consensus
Zacks News for MLYS
Wall Street Analysts See a 199.3% Upside in Mineralys Therapeutics, Inc. (MLYS): Can the Stock Really Move This High?
MLYS: What are Zacks experts saying now?
Zacks Private Portfolio Services